Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Cell Reports. Medicine|March 1, 2024
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patientsRuishan Liu, Lisa Wang, Shemra Rizzo, et al.
American Journal of Clinical Oncology|March 2, 2011
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinomaBenoit You, Christophe Le Tourneau, Eric X Chen, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 2, 2013
Adjuvant whole brain radiation following resection of brain metastasesDavid F Slottje, Joon-Hyung Kim, Lisa Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancerAnthony Brade, Andrea Bezjak, Robert MacRae, et al.
Nature Medicine|February 26, 2008
Dimorphic effects of Notch signaling in bone homeostasisFeyza Engin, Zhenqiang Yao, Tao Yang, et al.
Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.
Investigational New Drugs|March 2, 2010
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II ConsortiumSrikala S Sridhar, Eric Winquist, Andrea Eisen, et al.
Journal of the National Cancer Institute|November 1, 2014
Use and misuse of waterfall plotsTiffany Shao, Lisa Wang, Arnoud J Templeton, et al.
Targeted Oncology|June 18, 2024
Safety and Preliminary Efficacy of Once-Weekly Split-Dose Selinexor in Soft Tissue Sarcoma: Results of the Phase Ib METSSAR Clinical TrialAbdulazeez Salawu, Eoghan R Malone, Esmail Al-Ezzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumoursHelen J Mackay, Hal Hirte, Terrence Colgan, et al.
Pageof 17